Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Hofseth BioCare reported operating revenues of NOK 20.0 million in the second quarter of 2020, an increase of 57 percent compared to the similar period last year. Operating profit (EBITDA) in the...
-
In October 2019, Hofseth BioCare ASA (the "Company") entered into a consultancy agreement with James Berger. Under the terms of the consultancy agreement, Berger was granted 4,862,800 share options....
-
Hofseth BioCare ASA (“HBC”) pet care product Brilliant Salmon Oil™, a food and health supplement for dogs and cats, is now available in outlets across the UK, Spain, Iceland and online. This retail...
-
Hofseth BioCare ASA (“HBC”), today announces the completion of a purchase of 34 % stake in Hong Kong and China based finished products distributor Atlantic Delights Ltd (“AD”). Over the last five...
-
Dr. Hermansen is a qualified Orthopaedic surgeon based in Alesund, Norway where he was Head of the Surgical department Ålesund Hospital, Møre and Romsdal Hospital Trust. He has extensive experience in...
-
Reference is made to the decision by the general meeting of Hofseth BioCare ASA (the "Company") on 25 May 2020 to decrease the share capital with NOK 325,783,142.19 through a reduction of the par...
-
Reference is made to the decision by the general meeting of Hofseth BioCare ASA (the "Company") on 25 May 2020 to decrease the share capital with NOK 325,783,142.19 through a reduction of the par...
-
Reference is made to the stock exchange notice on 26 May 2020 and Hofseth BioCare ASA (“HBC”) announces that Health Canada has approved its accelerated phase 2 investigational trial protocol of CARDIO...
-
Hofseth BioCare ASA (“HBC”) forbereder en protokoll med KGK Science til Health Canada for å gjennomføre en fase 2 klinisk studie som skal vurdere OmeGo® i form av HBCs ferdigprodukt CARDIO...
-
Hofseth BioCare ASA (“HBC”) is preparing an investigational protocol with KGK Science into Health Canada to conduct a Phase 2 clinical trial assessing OmeGo® in the form of our branded product CARDIO...